Mono rapid testing is a type of point of care testing for the qualitative detection of mononucleosis heterophile antibodies in the whole blood. This test is only done for the diagnosis of infectious mononucleosis in the blood sample. Infectious mononucleosis is an acute lymphoproliferative disease. This disease is caused by Epstein-Barr virus (EBV) and it is non-recognizable disease during its early stages. The diagnosis of infectious mononucleosis is done by mono rapid test kits. This diagnosis is based on the on the evaluation of characteristic serological, clinical, and hematological changes in the blood sample. Physicians suggest to perform the mono rapid test for the detection of infectious mononucleosis if the patient is suffering from fever, pharyngitis, and cervical lymphadenopathy for more than 4 weeks. The result of mono rapid testing can be analyzed in few minute. There is no age restriction to perform the mono rapid testing. The mono rapid test kit includes a cassette, dropper, and reagents such as mono developer solution.
Mono Rapid Testing Market: Drivers and Restraints
Rising prevalence of infectious mononucleosis diseases due change in the lifestyle of people is the major factor driving the growth of the mono rapid testing market. Beside that mono rapid test kits provide an early and instant diagnosis which allows people for the better treatment option. The rising awareness among the people for the early and rapid diagnosis by using rapid test kits is also fuelling the growth of this market. Moreover, leading manufacturer of mono rapid test kits are also focusing on developing better products will also upsurge he growth of this market over the forecast period. The mono rapid test kit provides only qualitative detection of infectious mononucleosis and quantitative analysis of antigens is not possible with this test which wilt restraint the growth of this market to some extent. Results for mono rapid tests have to be recorded within the stipulated time as with the passage of time, the results are unreliable which will also responsible for the sluggish growth of this market.
Mono Rapid Testing Market: Segmentation
The global Mono Rapid Testing market is classified on the basis of product type, application, end user and geographic region.
Based on product type, mono rapid testing market is segmented into following:
Based on application type, mono rapid testing market is segmented into following:
Based on end user, mono rapid testing market is segmented into following:
Mono Rapid Testing Market: Overview
Mono rapid testing market is expected to gain remarkable growth over the forecast period due to increased focus of leading manufacturer to develop the better product for the diagnosis of infectious mononucleosis. Mono rapid testing is a highly fragmented market with majority of local players. The local players are expected to gain maximum market share for the mono rapid testing market. The trend of in-house laboratory for clinical testing in the physician office has increased the demand for the mono rapid test. Homecare setting and clinics are expected to gain major market share for the mono rapid testing market over the forecast period.
Mono Rapid Testing Market: Regional Overview
Based on geographic region Mono Rapid Testing market is classified into seven key regions, North, America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa. North America is expected to dominate the mono rapid testing market which is then followed by Western Europe and Asia-Pacific. The rapid adoption of rapid test kits and increasing awareness among the people will be responsible for the growth of North America and Western Europe. APEJ and Japan and the fastest growing owing to increasing geriatric population in this regions. Latin American and MEA are the least attractive region for the mono rapid testing market due to lack of awareness of people about infectious disease testing.
Mono Rapid Testing Market: Key Players
Examples of some of the market participants in Mono Rapid Testing market identified across the value chain include Cardinal Health, ELITech Group, Sekisui Diagnostics, Thermofisher Scientific Inc, Cortez Diagnostic, Inc., Quidel Corporation, Genzyme Diagnostics, Jant Pharmacal Corporation.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
Regional analysis includes:
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.